Faculty Chair for Medicine, Singularity University, | Founder and Chair, Exponential Medicine, Stanford, CA, USA
Vice President | Social Determinants of Health UnitedHealthcare Government Programs
Senior Vice President | The Lewin Group, Falls Church, VA, USA
Director | University of Ottawa Centre for Health Law, Policy and Ethics, Ottawa, ON, Canada
Canada Research Chair, Professor, and Research Director | University of Alberta, Edmonton, AB, Canada
Health Economist and Project HERCULES Chair | Patient Advisory Board, Duchenne UK, London, UK
Chief Commercial Officer | Spark Therapeutics, Inc., Philadelphia, PA, USA
Founder LORA Group, LLC and Affiliate Associate Professor, | University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Royal Oak, MD, USA
Vice-President | Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada
Kevin Marsh, PhD
Executive Director | Patient-Centered Research, Evidera Ltd, Newport Pagell, UK
Martin Ho, MS
Associate Director for Quantitative Innovation | Center for Devices and Radiological Health (CDRH), U.S. Food and Drug Administration, Silver Springs, MD, USA
Juan Marcos Gonzalez Sepulveda, PhD
Assistant Professor | Population Health Sciences, Preference Evaluation Research Group, Duke University, Durham, NC, USA
Sebastian Heidenreich, PhD
Senior Research Associate | Patient Preferences, Evidera, Aberdeen, UK
Chief Science Officer | Optum Labs
Associate Director, Research and Development | National Institute for Health and Care Excellence, London, United Kingdom
Instructor in Medicine | Brigham and Women’s Hospital, Boston, USA
Director | Pacmed, Amsterdam, The Netherlands
Professor, Pharmaceutical Health Services Research | University of Maryland, School of Pharmacy, Baltimore, MD, USA
Professor of Pharmaceutical and Health Economics | USC School of Pharmacy, Los Angeles, CA, USA
Vice President, Health Economics | RTI Health Solutions, Durham, NC, USA
Professor of Health Economics, Centre for Health Economics | University of York, Heslington, York, England, UK
Strategic Director | NEWDIGS and Visiting Scientist MIT, Boston, MA
Senior Vice President, Global Market Access | Merck
Principal & Founder | Hull Associates LLC, Rockland, MA, USA
Vice President & Head of Epidemiology and Real World Data Sciences, Medical Devices and Office of Chief Medical Officer | Johnson and Johnson, New Brunswick, NJ, USA
Medical Device Innovation Consortium | Washington, DC, USA
Director | Centre for Health Technology Evaluation, NICE, Manchester, UK
Professor, Pharmaceutical Outcomes Research & Policy Program | School of Pharmacy University of Washington, Seattle, WA, USA